Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation
Xinyuan Li(Qiqihar University), Xiaofeng Yang(Temple College), Muniswamy Madesh(The University of Texas at San Antonio), Satoru Eguchi(University of South Florida), Xiaohua Jiang(Fox Chase Cancer Center), Yin‐Ming Kuo(University of Pennsylvania), Candice Johnson(Unknown), Jianxin Sun(Second Military Medical University), Huimin Shan(Fox Chase Cancer Center), Hangfei Fu(Fox Chase Cancer Center), Walter J. Koch(Duke University), Fuyong Du(Fox Chase Cancer Center), Hong Wang(The First People's Hospital of Shunde), Yafeng Li(Shanxi Medical University), Pu Fang(Fox Chase Cancer Center), Nicholas E. Hoffman(Fox Chase Cancer Center), Daohai Yu(Fox Chase Cancer Center), Gayani Nanayakkara(Fox Chase Cancer Center), Andrew J. Andrews(Fox Chase Cancer Center)
Cited by 217
Related Papers
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
|Physiological Reviews|2018|1.1k
Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers
|Journal of Hematology & Oncology|2013|797
Adrenergic Nervous System in Heart Failure
|Circulation Research|2013|597
Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells.
|Journal of Clinical Investigation|1993|573